Arcellx Inc. (ACLX)
NASDAQ: ACLX
· Real-Time Price · USD
64.14
-1.86 (-2.82%)
At close: Jun 16, 2025, 3:59 PM
66.98
4.44%
After-hours: Jun 16, 2025, 07:21 PM EDT
-2.82% (1D)
| Bid | 62.06 |
| Market Cap | 3.53B |
| Revenue (ttm) | 76.81M |
| Net Income (ttm) | -162.42M |
| EPS (ttm) | -2.99 |
| PE Ratio (ttm) | -21.45 |
| Forward PE | -18.85 |
| Analyst | Buy |
| Ask | 70 |
| Volume | 483,068 |
| Avg. Volume (20D) | 759,774 |
| Open | 66.73 |
| Previous Close | 66.00 |
| Day's Range | 63.08 - 66.73 |
| 52-Week Range | 47.86 - 107.37 |
| Beta | 0.28 |
About ACLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+0.79%
Acrellx shares are trading lower after the company...
Unlock content with
Pro Subscription
10 months ago
+12.31%
Arcellx shares are trading higher after the company reported better-than-expected Q2 financial results.
2 months ago · businesswire.com
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of DirectorsREDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and...
